HYPR
Hyperfine, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.75
−3.24%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$0.78
From 52W high−59.64%
Volume551557.00
Market cap$80.05M
P/E (TTM)—
P/S (TTM)4.8x
Div yield—
Key dataOct 16, 2026
Open
$0.78
From 52W high
−59.64%
Volume
551557.00
Market cap
$80.05M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.5x
P/E (TTM)
—
RSI (14)
39.3
MomentumView details →
1D Return
−3.24%
YTD Return
−20.97%
SummaryUpdated Jun 1, 2026
Hyperfine, Inc. (NASDAQ:HYPR) is a medical device company founded in 2014 and based in Guilford, Connecticut. The company went public in January 2021 through a SPAC merger. Hyperfine develops and commercializes portable magnetic resonance imaging (MRI) technology, with its flagship product being the Swoop Portable MR imaging system. The company represents a pioneering effort to make MRI technology more accessible by creating a portable, point-of-care solution that can be deployed in various healthcare settings beyond traditional hospital radiology departments.
Similar companies
Latest newsMore news →
Hyperfine announced preliminary, unaudited third-quarter 2026 revenue of approximately $6.0 million, a record for the company.8d agoHyperfine, Inc. announced that it will report its third-quarter 2026 financial results on November 9, 2026, and hold a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.8d agoHyperfine appointed Roots Pharmaceutical as the exclusive distributor of its Swoop portable brain MRI system in the United Arab Emirates and Kuwait.18d ago